title: Managing adverse events of multiple myeloma and anti-multiple myeloma treatment: a perspective on carfilzomib.
authors.forename: David S
authors.initials: DS
authors.lastname: Siegel
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy*; D009842:Oligopeptides / Q000009:adverse effects*; D061988:Proteasome Inhibitors / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D009842:Oligopeptides; D061988:Proteasome Inhibitors; C524865:carfilzomib